Luteolin and neuroinflammation: a multi-target therapeutic strategy for central nervous system disorders. [PDF]
Huang J +7 more
europepmc +1 more source
Feline calicivirus localization in central nervous system cells of cats with neurological lesions. [PDF]
Phongroop K +5 more
europepmc +1 more source
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among patients with rheumatologic conditions and their associations with patient factors, patient‐reported perceived side effects, and positive impacts.
Susan Zhang +10 more
wiley +1 more source
Ultrasound-Based Therapies in Primary Central Nervous System Tumors. [PDF]
Dima G +10 more
europepmc +1 more source
Objective Studies of damage accrual in patients with systemic lupus erythematosus (SLE) show associations with disease activity measured by the SLE Disease Activity Index 2000 (SLEDAI‐2K), but these associations are imperfect. SLEDAI scores are powerfully influenced by weightings (1–8) assigned to each domain.
Kevin Zhang +8 more
wiley +1 more source
Overview of Primary Angiitis of the Central Nervous System: Current Insights. [PDF]
Phu A, Agrawal DK.
europepmc +1 more source
<i>Mycobacterium riyadhense</i> Infection Presenting as a Central Nervous System Mass: A Case Report. [PDF]
Bahabri I +5 more
europepmc +1 more source
The Gut–Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort
Objective Cardiac involvement significantly impacts prognosis in systemic sclerosis (SSc), highlighting the need for early risk stratification. Gastrointestinal (GI) symptoms are common and often manifest early. Emerging data suggest a link between GI and cardiac manifestations, possibly through shared mechanisms like dysautonomia.
Francesca R. Di Ciommo +9 more
wiley +1 more source
Orbital alveolar rhabdomyosarcoma with central nervous system invasion in adult: A case report. [PDF]
Della Bona DS +8 more
europepmc +1 more source
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)
Objective VEXAS syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures. A VEXAS‐specific disease activity index (DAI) is an essential tool for reliably capturing changes in disease ...
Kevin Byram +25 more
wiley +1 more source

